- Home
- SCOR vs IBIO Comparison
SCOR vs IBIO Comparison
Compare SCOR & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- IBIO
- Stock Information
- Founded
- SCOR 1999
- IBIO 2008
- Country
- SCOR United States
- IBIO United States
- Employees
- SCOR N/A
- IBIO N/A
- Industry
- SCOR Business Services
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- IBIO Health Care
- Exchange
- SCOR Nasdaq
- IBIO Nasdaq
- Market Cap
- SCOR 27.7M
- IBIO 24.3M
- IPO Year
- SCOR 2007
- IBIO N/A
- Fundamental
- Price
- SCOR $5.50
- IBIO $0.81
- Analyst Decision
- SCOR Buy
- IBIO Strong Buy
- Analyst Count
- SCOR 2
- IBIO 3
- Target Price
- SCOR $10.75
- IBIO $4.87
- AVG Volume (30 Days)
- SCOR 8.8K
- IBIO 1.2M
- Earning Date
- SCOR 05-06-2025
- IBIO 05-12-2025
- Dividend Yield
- SCOR N/A
- IBIO N/A
- EPS Growth
- SCOR N/A
- IBIO N/A
- EPS
- SCOR N/A
- IBIO N/A
- Revenue
- SCOR $356,047,000.00
- IBIO $375,000.00
- Revenue This Year
- SCOR $4.38
- IBIO $36.00
- Revenue Next Year
- SCOR $3.97
- IBIO $33.33
- P/E Ratio
- SCOR N/A
- IBIO N/A
- Revenue Growth
- SCOR N/A
- IBIO 650.00
- 52 Week Low
- SCOR $4.59
- IBIO $0.87
- 52 Week High
- SCOR $15.69
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- SCOR 46.17
- IBIO 19.10
- Support Level
- SCOR $4.59
- IBIO $0.64
- Resistance Level
- SCOR $5.63
- IBIO $1.00
- Average True Range (ATR)
- SCOR 0.61
- IBIO 0.32
- MACD
- SCOR -0.01
- IBIO -0.10
- Stochastic Oscillator
- SCOR 53.22
- IBIO 3.55
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.